FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087804374> ?p ?o ?g. }

• W3087804374 endingPage "222" @default.
• W3087804374 startingPage "210" @default.
• W3087804374 abstract "AIMS :  Investigation of spontaneous and induced secretion of the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) and the anti-inflammatory chemokine C-C Motif Chemokine Ligand 18 (CCL18) by monocytes isolated from blood of patients with long-term type 2 diabetes mellitus (T2DM), both with or without foot ulcers and the effect of the course use of the combined metabolic drug Kokarnit as part of complex therapy on the dynamics of the severity of symptoms of DSPN and the cytokine phenotype in patients with long-term non-healing ulcers of the lower extremities MATERIALS AND METHODS :  121 patients with T2DM, 79 without diabetic foot syndrome (DFS) and 42 patients with DFS were included. CD14+ monocytes were isolated from patients’ blood and stimulated by interferon-γ (IFN-γ) and interleukine-4 (IL-4) for induction of pro- and anti-inflammatory monocyte activation, respectively. The concentrations of TNF-α and CCL18 in the culture medium were measured using ELISA on day 1 and day 6 after cell stimulation in all patients before taking the combined metabolic drug Kokarnit. Then they were randomly allocated either to the control group (57 people), to whom Kokarnit was added to standard treatment, or to the comparison group. After a 9-day course of application of Kokarnit, the dynamics of indicators was evaluated on a TSS scale. Assessment of cytokine status was carried out in 18 people with long-term non-healing ulcerative defects of the lower extremities, on the first and ninth day of treatment. RESULTS :  A correlation was found between HbA 1c  and levels of stimulated secretion of TNFα (r=0.726, p=0.027), CCL18 (r=-0.949, p=0.051) in patients with DSPN. In all patients with different duration of VDS, an increase in secretion of TNF-α and CCL18 was observed (p<0.05). However, stimulation of anti-inflammatory activation was not observed in patients with ulcerative defects lasting more than 6 months (p=0.033). The use of cocarnit in these patients had a decrease in stimulated secretion of TNFα and an increase in CCL18. Throughout the entire observation period with the therapy, the score for the symptoms of polyneuropathy on the TSS scale in patients of the control group was statistically significantly higher. CONCLUSION:  Against the background of therapy in patients of the main group, a statistically significant dynamics of indicators on the TSS scale was established. The cytokine modulating ability of Kokarnit to switch the cytokine status into the category of anti-inflammatory." @default.
• W3087804374 created "2020-10-01" @default.
• W3087804374 creator A5001973905 @default.
• W3087804374 creator A5005003488 @default.
• W3087804374 creator A5027365983 @default.
• W3087804374 creator A5068318646 @default.
• W3087804374 creator A5070741354 @default.
• W3087804374 creator A5075305832 @default.
• W3087804374 creator A5089338821 @default.
• W3087804374 date "2020-08-10" @default.
• W3087804374 modified "2023-09-27" @default.
• W3087804374 title "Спонтанная и индуцированная секреция провоспалительных и противовоспалительных цитокинов у пациентов с сахарным диабетом 2 типа и синдромом диабетической стопы" @default.
• W3087804374 doi "https://doi.org/10.14341/dm12343-9690" @default.
• W3087804374 hasPublicationYear "2020" @default.
• W3087804374 type Work @default.
• W3087804374 sameAs 3087804374 @default.
• W3087804374 citedByCount "0" @default.
• W3087804374 crossrefType "journal-article" @default.
• W3087804374 hasAuthorship W3087804374A5001973905 @default.
• W3087804374 hasAuthorship W3087804374A5005003488 @default.
• W3087804374 hasAuthorship W3087804374A5027365983 @default.
• W3087804374 hasAuthorship W3087804374A5068318646 @default.
• W3087804374 hasAuthorship W3087804374A5070741354 @default.
• W3087804374 hasAuthorship W3087804374A5075305832 @default.
• W3087804374 hasAuthorship W3087804374A5089338821 @default.
• W3087804374 hasConcept C126322002 @default.
• W3087804374 hasConcept C13373296 @default.
• W3087804374 hasConcept C170493617 @default.
• W3087804374 hasConcept C17991360 @default.
• W3087804374 hasConcept C203014093 @default.
• W3087804374 hasConcept C2776914184 @default.
• W3087804374 hasConcept C2778513237 @default.
• W3087804374 hasConcept C2778690821 @default.
• W3087804374 hasConcept C2781184567 @default.
• W3087804374 hasConcept C71924100 @default.
• W3087804374 hasConcept C90924648 @default.
• W3087804374 hasConceptScore W3087804374C126322002 @default.
• W3087804374 hasConceptScore W3087804374C13373296 @default.
• W3087804374 hasConceptScore W3087804374C170493617 @default.
• W3087804374 hasConceptScore W3087804374C17991360 @default.
• W3087804374 hasConceptScore W3087804374C203014093 @default.
• W3087804374 hasConceptScore W3087804374C2776914184 @default.
• W3087804374 hasConceptScore W3087804374C2778513237 @default.
• W3087804374 hasConceptScore W3087804374C2778690821 @default.
• W3087804374 hasConceptScore W3087804374C2781184567 @default.
• W3087804374 hasConceptScore W3087804374C71924100 @default.
• W3087804374 hasConceptScore W3087804374C90924648 @default.
• W3087804374 hasIssue "3" @default.
• W3087804374 hasLocation W30878043741 @default.
• W3087804374 hasOpenAccess W3087804374 @default.
• W3087804374 hasPrimaryLocation W30878043741 @default.
• W3087804374 hasVolume "23" @default.
• W3087804374 isParatext "false" @default.
• W3087804374 isRetracted "false" @default.
• W3087804374 magId "3087804374" @default.
• W3087804374 workType "article" @default.